Medpace Holdings (MEDP) Financials: History & Chart

Medpace Holdings, Inc. (MEDP)MEDPMedpace Holdings, Inc.

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH

6,200 employees

www.medpace.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: August James Troendle

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	2.78B	707.33M	706.60M	708.45M	659.90M	603.31M	558.57M	536.59M	533.32M
Cost of Goods Sold	1.98B	505.69M	510.28M	503.13M	462.96M	423.30M	380.22M	358.27M	364.31M
Gross Profit	800.22M	201.64M	196.33M	205.32M	196.94M	180.01M	178.35M	178.32M	169.01M
Gross Profit Margin	28.8%	28.5%	27.8%	29.0%	29.8%	29.8%	31.9%	33.2%	31.7%
Total Operating Expenses	216.81M	54.81M	54.82M	52.05M	55.13M	53.68M	64.83M	52.94M	56.73M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	189.02M	48.10M	47.92M	44.92M	48.08M	46.66M	57.90M	45.43M	49.22M
Operating Income (EBIT)	583.40M	146.82M	141.50M	153.27M	141.81M	126.33M	113.52M	125.38M	112.27M
Operating Margin	21.0%	20.8%	20.0%	21.6%	21.5%	20.9%	20.3%	23.4%	21.1%
Income Before Tax (EBT)	598.92M	151.66M	147.59M	156.83M	142.84M	124.54M	118.17M	133.88M	118.78M
Interest Income	1.52M	-5.12M	5.12M	N/A	1.52M	1.08M	6.46M	7.88M	7.53M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	15.52M	4.84M	6.09M	3.56M	1.03M	-1.80M	4.65M	8.50M	6.50M
Net Income	491.50M	121.36M	123.87M	135.13M	111.14M	90.26M	114.59M	117.02M	96.43M
Income Tax Expense	107.42M	30.30M	23.72M	21.70M	31.70M	34.28M	3.58M	16.86M	22.35M
Net Profit Margin	17.7%	17.2%	17.5%	19.1%	16.8%	15.0%	20.5%	21.8%	18.1%
EBITDA	591.50M	133.83M	148.41M	160.40M	148.86M	133.35M	120.45M	132.88M	119.79M
EBITDA Margin	21.3%	18.9%	21.0%	22.6%	22.6%	22.1%	21.6%	24.8%	22.5%
Depreciation & Amortization	14.18M	-6.91M	6.91M	7.13M	7.05M	7.01M	6.93M	7.51M	7.52M
EPS Basic	17.39	4.31	4.35	4.78	3.95	3.16	3.77	3.78	3.11
EPS Diluted	17.07	4.25	4.28	4.67	3.87	3.10	3.67	3.67	3.01
Shares Outstanding	28.31M	28.31M	28.45M	28.29M	29.03M	29.49M	30.39M	30.95M	31.05M
Diluted Shares Outstanding	28.76M	28.76M	28.96M	28.96M	29.71M	30.16M	31.20M	32.01M	32.09M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.53B	2.11B	1.89B	1.46B	1.14B	925.92M	860.97M	704.59M
Cost of Goods Sold	1.77B	1.45B	1.36B	1.03B	814.22M	647.20M	615.27M	489.06M
Gross Profit	760.62M	656.30M	524.50M	432.44M	328.15M	278.73M	245.70M	215.53M
Gross Profit Margin	30.1%	31.1%	27.8%	29.6%	28.7%	30.1%	28.5%	30.6%
Total Operating Expenses	225.68M	209.44M	187.68M	153.74M	129.54M	111.68M	118.43M	114.48M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	197.56M	180.18M	161.35M	131.40M	108.42M	92.16M	95.25M	75.68M
Operating Income (EBIT)	534.93M	446.87M	336.82M	278.70M	198.62M	167.04M	127.26M	101.05M
Operating Margin	21.1%	21.2%	17.9%	19.1%	17.4%	18.0%	14.8%	14.3%
Income Before Tax (EBT)	542.38M	475.92M	335.68M	282.86M	201.85M	168.53M	124.83M	93.95M
Interest Income	N/A	25.00M	N/A	N/A	N/A	307K	N/A	N/A
Interest Expense	N/A	N/A	488K	2.90M	105K	N/A	1.57M	8.16M
Other Income/Expense	7.44M	29.05M	-1.14M	4.16M	3.24M	1.49M	-2.43M	-7.10M
Net Income	451.12M	404.39M	282.81M	245.37M	181.85M	145.38M	100.44M	73.19M
Income Tax Expense	91.25M	71.54M	52.87M	37.49M	20.00M	23.15M	24.39M	20.77M
Net Profit Margin	17.8%	19.2%	15.0%	16.8%	15.9%	15.7%	11.7%	10.4%
EBITDA	563.06M	476.12M	363.15M	301.04M	219.73M	186.57M	150.45M	139.85M
EBITDA Margin	22.3%	22.6%	19.3%	20.6%	19.2%	20.1%	17.5%	19.8%
Depreciation & Amortization	28.12M	29.25M	26.33M	22.34M	21.12M	19.53M	23.19M	38.80M
EPS Basic	15.64	13.06	9.20	7.57	5.06	4.07	2.79	2.05
EPS Diluted	15.28	12.63	8.88	7.28	4.81	3.84	2.67	1.97
Shares Outstanding	28.85M	30.96M	30.72M	32.39M	35.86M	35.63M	35.88M	35.55M
Diluted Shares Outstanding	29.53M	32.01M	31.84M	33.67M	37.70M	37.71M	37.58M	36.91M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.